|
|
|
Volumn 281, Issue 5, 1999, Pages
|
|
Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
MEVINOLIN;
SIMVASTATIN;
CORONARY ARTERY DISEASE;
HUMAN;
NOTE;
COST BENEFIT ANALYSIS;
ECONOMICS;
QUALITY OF LIFE;
RISK;
ANTI-ARRHYTHMIA AGENTS;
ANTICHOLESTEREMIC AGENTS;
CORONARY DISEASE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LOVASTATIN;
SIMVASTATIN;
COST-BENEFIT ANALYSIS;
QUALITY OF LIFE;
RISK;
|
|
EID: 0033518419
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
